Preparation of a Klebsiella pneumoniae conjugate nanovaccine using glycol-engineered Escherichia coli
Abstract Background Engineered strains of Escherichia coli have been used to produce bioconjugate vaccines using Protein Glycan Coupling Technology (PGCT). Nanovaccines have also entered the vaccine development arena with advances in nanotechnology and have been significantly developed, but chassis...
Main Authors: | Yan Liu, Chao Pan, Kangfeng Wang, Yan Guo, YanGe Sun, Xiang Li, Peng Sun, Jun Wu, Hengliang Wang, Li Zhu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-05-01
|
Series: | Microbial Cell Factories |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12934-023-02099-x |
Similar Items
-
Efficient Production of Self-Assembled Bioconjugate Nanovaccines against <i>Klebsiella pneumoniae</i> O2 Serotype in Engineered <i>Escherichia coli</i>
by: Yan Zhang, et al.
Published: (2024-04-01) -
Production of a Promising Biosynthetic Self‐Assembled Nanoconjugate Vaccine against Klebsiella Pneumoniae Serotype O2 in a General Escherichia Coli Host
by: Zhehui Peng, et al.
Published: (2021-07-01) -
Production of Promising Heat-Labile Enterotoxin (LT) B Subunit-Based Self-Assembled Bioconjugate Nanovaccines against Infectious Diseases
by: Caixia Li, et al.
Published: (2024-03-01) -
Construction of Orthogonal Modular Proteinaceous Nanovaccine Delivery Vectors Based on mSA-Biotin Binding
by: Yixin Shi, et al.
Published: (2022-02-01) -
Genetic Engineering of <i>Klebsiella pneumoniae</i> ATCC 25955 for Bioconjugate Vaccine Applications
by: Yan Liu, et al.
Published: (2023-05-01)